93 related articles for article (PubMed ID: 10949120)
1. Synthesis and pharmacological characteristics of novel (Z)-3-arylidene-indolin-2(1H)-ones: preliminary results.
Mokrosz MJ; Charakchieva-Minol S; Kozioł A; Kłodzińska A; Chojnacka-Wójcik E
Pol J Pharmacol; 2000; 52(1):47-50. PubMed ID: 10949120
[TBL] [Abstract][Full Text] [Related]
2. Influence of the terminal amide fragment geometry in some 3-arylideneindolin-2(1H)-ones on their 5-HT1A/5-HT2A receptor activity.
Mokrosz MJ; Charakchieva-Minol S; Kozioł A; Kłodzińska A; Chojnacka-Wójcik E
Bioorg Med Chem Lett; 2001 May; 11(9):1229-31. PubMed ID: 11354383
[TBL] [Abstract][Full Text] [Related]
3. Substitution mode of the amide fragment in some new N-[omega-[4-(2-methoxyphenyl)piperazin-1-yl]alkyl]pyrid-2(1H)-ones and their 5-HT1A/5-HT2A activity.
Paluchowska MH; Bugno R; Charakchieva-Minol S; Bojarski AJ; Wesołowska A
Pol J Pharmacol; 2001; 53(4):369-76. PubMed ID: 11990083
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
Chloń G; Pawłowski M; Duszyńska B; Szaro A; Tatarczńska E; Kłodzińska AL; Chojnacka-Wójcik E
Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
[TBL] [Abstract][Full Text] [Related]
5. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1A and 5-HT2A receptor affinity and functional profile of some N-[3-(4-aryl-1-piperazinyl)propyl] derivatives of indolin-2(1H)-one, quinolin-2(1 H)-one and isoquinolin-1(2H)-one. Part 30: Structure-activity relationship studies of CNS agents.
Mokrosz MJ; Mokrosz JL; Duszyńska B; Dereń-Wesołek A; Kłodzińska A; Kowalski P; Charakchieva-Minol S; Tatarczyńska E; Kowalska T; Majka Z; Chojnacka-Wójcik E; Misztal S
Pharmazie; 1997 Jun; 52(6):423-8. PubMed ID: 9260266
[TBL] [Abstract][Full Text] [Related]
7. Effect of the amide fragment on 5-HT1A receptor activity of some analogs of MP 3022.
Paluchowska MH; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A
Pol J Pharmacol; 1999; 51(5):415-21. PubMed ID: 10817542
[TBL] [Abstract][Full Text] [Related]
8. 2-H- and 2-acyl-9- [omega-[4-(2-methoxyphenyl)piperazinyl]-alkyl]-1,2,3,4-tetrahydro-beta-carbolines as ligands of 5-HT1A and 5-HT2A receptors.
Boksa J; Mokrosz MJ; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A; Wesołowska A; Misztal S
Pol J Pharmacol; 2001; 53(5):501-8. PubMed ID: 11990069
[TBL] [Abstract][Full Text] [Related]
9. Modification of the structure of 4, 6-disubstituted 2-(4-alkyl-1-piperazinyl)pyridines: synthesis and their 5-HT2A receptor activity.
Paluchowska MH; Bojarski AJ; Bugno R; Charakchieva-Minol S; Wesołowska A
Arch Pharm (Weinheim); 2003 Apr; 336(2):104-10. PubMed ID: 12761763
[TBL] [Abstract][Full Text] [Related]
10. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
[TBL] [Abstract][Full Text] [Related]
11. A search for new 5-HT1A/5-HT2A receptor ligands. In vitro and in vivo studies of 1-[omega-(4-aryl-1-piperazinyl)alkyl]indolin-2(1H)-ones.
Mokrosz MJ; Duszyńska B; Misztal S; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E; Dziedzicka-Wasylewska M
Arch Pharm (Weinheim); 1998 Oct; 331(10):325-30. PubMed ID: 9844580
[TBL] [Abstract][Full Text] [Related]
12. New 2-piperazinylbenzimidazole derivatives as 5-HT3 antagonists. Synthesis and pharmacological evaluation.
Orjales A; Mosquera R; Labeaga L; Rodes R
J Med Chem; 1997 Feb; 40(4):586-93. PubMed ID: 9046349
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship studies of CNS agents. Part 14: Structural requirements for the 5-HT1A and 5-HT2A receptor selectivity of simple 1-(2-pyrimidinyl)piperazine derivatives.
Mokrosz JL; Strekowski L; Duszyńska B; Harden DB; Mokrosz MJ; Bojarski AJ
Pharmazie; 1994 Nov; 49(11):801-6. PubMed ID: 7838864
[TBL] [Abstract][Full Text] [Related]
14. Arylpiperazine derivatives of 3-propyl-beta-tetralonohydantoin as new 5-HT1A and 5-HT2A receptor ligands.
Byrtus H; Pawłowski M; Duszyńska B; Wesołowska A; Chojnacka-Wójcik E; Bojarski AJ
Pol J Pharmacol; 2001; 53(4):395-401. PubMed ID: 11990087
[TBL] [Abstract][Full Text] [Related]
15. Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.
Heffernan GD; Coghlan RD; Manas ES; McDevitt RE; Li Y; Mahaney PE; Robichaud AJ; Huselton C; Alfinito P; Bray JA; Cosmi SA; Johnston GH; Kenney T; Koury E; Winneker RC; Deecher DC; Trybulski EJ
Bioorg Med Chem; 2009 Nov; 17(22):7802-15. PubMed ID: 19836247
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro and in vivo 5-HT1A/5-HT2A serotonin receptor activity of new hybrid 1,2,3,4-tetrahydro-gamma-carbolines with 1-(2-methoxyphenyl)piperazine moiety.
Boksa J; Charakchieva-Minol S; Duszyńska B; Bugno R; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E; Bojarski AJ
Pol J Pharmacol; 2003; 55(6):1013-9. PubMed ID: 14730096
[TBL] [Abstract][Full Text] [Related]
17. New 4-[omega-(diarylmethylamino)alkyl]- and 4-[omega-(diarylmethoxy)alkyl]-1-arylpiperazines as selective 5-HT1A/5-HT2A receptor ligands with differentiated in vivo activity.
Paluchowska MH; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
Pol J Pharmacol; 2004; 56(6):743-54. PubMed ID: 15662087
[TBL] [Abstract][Full Text] [Related]
18. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
[TBL] [Abstract][Full Text] [Related]
19. Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands.
Caliendo G; Fiorino F; Perissutti E; Severino B; Gessi S; Cattabriga E; Borea PA; Santagada V
Eur J Med Chem; 2001; 36(11-12):873-86. PubMed ID: 11755230
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
